Invesco India Pharma and Healthcare Fund
Invesco Mutual Fund · Sectoral/Thematic · Regular plan, growth option
NAV (₹), 2 Oct 2026
9.5500
1-day change
-0.31%
1Y return
n/a
3Y CAGR
n/a
5Y CAGR
n/a
Max drawdown, 5Y
n/a
Returns vs Sectoral/Thematic median (259 schemes) and “Healthcare & pharma” median (19)
| Period | Scheme | Category median | Healthcare & pharma median |
|---|---|---|---|
| 1 month | n/a | -5.4% | -3.2% |
| 3 months | n/a | -3.1% | 2.7% |
| 6 months | n/a | 8.5% | 21.0% |
| Year to date | n/a | -2.6% | 16.3% |
| 1 year | n/a | 0.0% | 16.0% |
| 3 years (CAGR) | n/a | 11.7% | 19.2% |
| 5 years (CAGR) | n/a | 10.6% | 13.7% |
| 7 years (CAGR) | n/a | 15.7% | 23.7% |
| 10 years (CAGR) | n/a | 13.3% | 13.4% |
| Since first NAV (CAGR) | n/a | – | – |
“Healthcare & pharma” is MFIC's grouping of Sectoral/Thematic schemes by the theme or index in their names, not an AMFI category.
Rolling returns every business-day start date
| Measure | Scheme | Category median |
|---|---|---|
| 1Y rolling median | n/a | 9.8% |
| 3Y rolling median | n/a | 15.6% |
| 3Y rolling worst | n/a | 0.6% |
| 3Y periods positive | n/a | 100% |
| 3Y periods ahead of benchmark | n/a | 71% |
| 5Y rolling median | n/a | 14.2% |
| 5Y rolling worst | n/a | 0.3% |
| 5Y periods ahead of benchmark | n/a | 70% |
Benchmark: Nifty 500 (proxy: Motilal Oswal Nifty 500 Index Fund, price return).
Risk 36 months, monthly returns, Rf 6.5%
| Measure | Scheme | Category median |
|---|---|---|
| Standard deviation (ann.) | n/a | 16.7% |
| Sharpe ratio | n/a | 0.34 |
| Sortino ratio | n/a | 0.51 |
| Beta | n/a | 0.96 |
| Alpha (ann.) | n/a | 2.3% |
| Upside capture | n/a | 103.56 |
| Downside capture | n/a | 96.87 |
Drawdowns peak-to-trough falls in NAV
| Measure | Scheme | Category median |
|---|---|---|
| Maximum drawdown, full history | n/a | −23.7% |
| Maximum drawdown, last 10Y | n/a | −39.3% |
| Maximum drawdown, last 5Y | n/a | −22.8% |
| Current drawdown | n/a | −8.8% |
| Recovery time of worst fall | n/a | – |
Longer histories include more crises, so compare the 5Y and 10Y figures across schemes of different ages.
Cost, size and riskometer as disclosed to AMFI
| Measure | Scheme | Category median |
|---|---|---|
| Expense ratio (TER), Regular plan | 5.19% | 2.65% |
| AUM, whole scheme (₹ crore) | n/a | 1,245 |
| Riskometer | n/a | – |
TER: AMFI, TER of MF Schemes. AUM and riskometer: AMFI, Fund Performance, 30 Sep 2026.
Official benchmark and category consistency
| Measure | Scheme | Benchmark / category |
|---|
Category consistency: last 10 years of month-ends, Sectoral/Thematic Regular plans; how it is calculated.
Scheme facts
AMC: Invesco Mutual Fund
Category: Sectoral/Thematic
Plan / option: Regular · Growth
AMFI scheme code: 154545
ISIN: INF205KA1BU1
First NAV in MFIC data: 10 Sep 2026
History: 0.1 years
Expense ratio, AUM, portfolio: see the scheme's factsheet
Questions about Invesco India Pharma and Healthcare Fund
- What is the latest NAV of Invesco India Pharma and Healthcare Fund?
- The NAV of the Regular plan (growth option) was ₹9.5500 on 2 Oct 2026, as published by AMFI.
- Which category is Invesco India Pharma and Healthcare Fund in?
- It is classified as Sectoral/Thematic in AMFI's daily NAV file; a Sectoral/Thematic scheme invests at least 80% in one sector or theme. MFIC compares it with 259 Sectoral/Thematic schemes (Regular plans).
- What is the expense ratio (TER) of Invesco India Pharma and Healthcare Fund?
- The total expense ratio of the Regular plan is 5.19% a year, as disclosed to AMFI (median of Sectoral/Thematic Regular plans: 2.65%). It is already deducted from the NAV, so every return shown is after expenses.
Reviewing your own mutual fund portfolio?
Integrato's team can walk you through how your current schemes have behaved, using the same data shown here. Integrato is an AMFI-registered Mutual Fund Distributor.
Follow Invesco India Pharma and Healthcare Fund by email
Every Monday: this scheme's NAV, 1-month and 1-year return beside its category median, 3-year CAGR and how far it is below its peak. Add more schemes from their pages or from your MFIC watchlist. Free; unsubscribe from any email.
Data & disclosure. Source: AMFI daily NAV file and historical NAVs via mfapi.in; calculations by MFIC, as of 2 Oct 2026. Category medians use Regular plans in the same AMFI category. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance may or may not be sustained in future. This page is for research and education only and is not investment advice or a recommendation to buy, sell or hold any scheme. Integrato Financial Services Pvt. Ltd. is an AMFI-registered Mutual Fund Distributor (ARN-173155). Methodology.